Gasco, Mary Grace .
HRN: 11-82-25 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/26/2023
CEFUROXIME 500MG (TAB)
03/26/2023
04/02/2023
PO
500 Mg
BID
SP NSVD RMLE W/ Repair
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes